Addictions are chronic, often relapsing disorders characterized by obsession, compulsion, or physical or psychological dependence. The World Health Organization estimates that there are 2 billion alcohol users, 1.3 billion tobacco users and 185 million illicit drug users worldwide. Twin and family studies provide strong evidence that addictions involve the interplay of genetic and environmental factors [1] [2] [3] [4] [5] . Greater knowledge of the genetics underlying addiction therefore is crucial for the development of more effective interventions. For example, after attempting to quit, smokers of European ancestry with the CYP2B6*6 genotype in the cytochrome p450 gene are more likely to relapse than smokers of other genotypes when on placebo, but they can be helped by bupropion treatment 6 . In recent years, significant progress has been made in identifying susceptibility genes for addictions. Given that most of this progress, which has been focused primarily on addiction to single substances, has been covered in other reviews [1] [2] [3] [4] [5] 7 , we focus here on the most recent advances made through the use of linkage and association approaches, especially with genome-wide association (GWA) studies; our goal is to provide an updated summary of identified susceptibility loci or genes for multiple substances. Regions on human chromosomes 4, 5, 9-11 and 17 are more likely to harbour susceptibility genes for multiple substances.
. Greater knowledge of the genetics underlying addiction therefore is crucial for the development of more effective interventions. For example, after attempting to quit, smokers of European ancestry with the CYP2B6*6 genotype in the cytochrome p450 gene are more likely to relapse than smokers of other genotypes when on placebo, but they can be helped by bupropion treatment 6 . In recent years, significant progress has been made in identifying susceptibility genes for addictions. Given that most of this progress, which has been focused primarily on addiction to single substances, has been covered in other reviews [1] [2] [3] [4] [5] 7 , we focus here on the most recent advances made through the use of linkage and association approaches, especially with genome-wide association (GWA) studies; our goal is to provide an updated summary of identified susceptibility loci or genes for multiple substances. Regions on human chromosomes 4, 5, 9-11 and 17 are more likely to harbour susceptibility genes for multiple substances.
Among the susceptibility genes for addiction identified from candidate gene-based or GWA approaches, we limit our focus to genes in the aldehyde dehydrogenase (ADH) gene cluster, and the genes encoding nicotinic acetylcholine receptor (nAChR) subunits, gamma-aminobutyric acid A (GABA A ) receptor subunit 2 (GABRA2), ankyrin repeat and kinase domain containing 1 (ANKK1) and neurexins. This is because of the influence of these genes on susceptibility to addiction to multiple substances, the strong statistical evidence to support their roles, or the importance of their biological functions in addiction.
We first focus on evidence for the contribution of genetics to addiction, then on the recently identified loci and genes that confer susceptibility to multiple substances, and finally on the knowledge gained from engineered mice.
Genetic contribution to addiction
Epidemiological studies strongly suggest that genetic factors operate at all steps of addiction, including vulnerability to initiation, continued use and propensity to become dependent
. There have been many twin studies investigating the relative contributions of genetic and environmental factors. In addition to estimating genetic liability, twin studies provide information about environmental contributions, including the availability of and exposure to a substance, and shared and unique environments. The genetic influence on addiction has proved to be substantial, and heritabilities for most addictive disorders are moderate to high.
Numerous large twin studies for alcohol-related behaviours have consistently shown that heritability of alcohol abuse and dependence ranges from 50% to 70% 8 . A similarly high heritability is seen across other alcohol-related behaviours, including heavy consumption and 'problem' drinking 8 . Meta-analysis of the twin studies shows that both genes and environment are important in smoking-related behaviours, with an estimated mean heritability of 0.50 for smoking initiation and 0.59 for nicotine dependence (ND) 4 . In women, genetic factors have a larger role in initiation than in persistence, whereas the opposite is observed in men 4, 9 . Fewer studies have examined genetic influences on illicit drug addiction. Heritability of the use and/or dependence on stimulants, sedatives and heroin in males is 0.33, 0.27 and 0.54, respectively 10 . These values are similar to those seen in females, although such studies are rarer 11 . Moreover, twin studies indicate a large overlap between the genetic predispositions to dependence to most classes of substance. For example, twin studies suggest that nicotine and alcohol dependencies share more than 60% of their genetic vulnerabilities 12 . Finally, we point out that heritability is specific to the sample under study. Thus, the role of genetic influences may differ across samples, and heritability may be affected by many factors, such as sex, age, education, socioeconomic status and cultural background.
Identifying susceptibility loci for addiction Both linkage mapping and association mapping have identified susceptibility loci for addiction-related phenotypes, especially for alcohol dependence (AD) and ND. However, few putative genome linkages have been replicated in independent studies, probably because of genetic heterogeneity.
Despite these limitations, significant progress has been made, especially for AD and ND. Linkage studies have identified a locus on chromosome 4q near the ADH gene cluster as a major locus for alcoholism in American Indians and Caucasians [13] [14] [15] , in addition to the known ADH2 and aldehyde dehydrogenase 2 (ALDH2) variants in Asians and Jewish Americans [16] [17] [18] . The ADH locus contains a cluster of seven genes, of which ADH2 is the most important across populations 19 , although functional variants in ADH4 and ADH7 might also be involved 16, 20, 21 . One of the most successful examples of the positional candidate gene approach in addiction research has been the identification of GABRA2 as a susceptibility factor for alcoholism. Early linkage studies in southwest American Indians 13 implicated chromosome 4p near the GABRA2-GABRB1 cluster; these results were confirmed in some Caucasian studies 22 , and became particularly convincing when linkage of alcohol-related phenotypes was combined with QTL mapping of electroencephalographic quantitative trait data 23 . Initial association findings for GABRA2 (Ref. 24) in that linkage region were replicated in multiple studies [25] [26] [27] , so that GABRA2 is now considered a confirmed risk locus for AD.
similarly, variants in GABBR2 (on chromosome 9q22), which encodes GABA B receptor subunit 2, have been associated with ND 28 . Linkage of chromosome 9 with smoking behaviour has been reported in several independent studies [29] [30] [31] [32] , and GABBR2 accounts for 28%-38% of this linkage signal 33 . The involvement of GABA signalling across addictions has been confirmed in animal models (see later section).
Although many linkage scans have been reported for addiction to a specific drug, only a few have investigated the convergence of linkage peaks across drug addictions. Towards this objective, we searched for linkage peaks among multiple abused substances, according to the criteria proposed by Lander and Kruglyak 34 . We found that regions on chromosomes 2-5, 7, 9-11, 13, 14 and 17 have independent evidence of 'suggestive' or 'significant' linkage, with regions on chromosomes 4, 5, 9, 10, 11 and 17 receiving the strongest support for harbouring susceptibility genes for addictions to multiple drugs (fIG. 1) .
Although many candidate genes have been investigated for associations with addiction, only a few findings have been replicated in independent studies for multiple addictions. Instead of giving a detailed review of these candidates individually, our discussion focuses on representative genes that have recently received much attention or are associated with addictions to multiple substances.
Susceptibility genes for substance addiction
In the past 2 years, the most significant findings in addiction genetics have been the involvement of a few nAChR subunit genes specifically in ND and more generally in substance abuse. As illustrated in BOX 2,  nicotine exerts its biological function by binding to nAChRs, which are composed of five subunits. There are 12 nAChR subunit genes: nine alpha (α2-α10) and three beta (β2-β4). variants have been associated with dependence on nicotine, alcohol and cocaine, and with lung cancer susceptibility, as explained below. nAChRα4 subunit gene. A significant association of variants in CHRNA4, which encodes the α4 subunit, with ND has been detected in three independent studies. The first study revealed significant protective effects of two sNps against ND in Chinese men 35 . A second study showed that four sNps, and haplotypes that consist of these sNps, are significantly associated with ND in European and African Americans, but the effects differed as a function of ethnicity or sex 36 . A third study reported that two sNps are significantly associated with the subjective response to smoking 37 . Although not all of these associations have been replicated, two sNps (rs1044396 and rs2236196) are consistent in two of the three studies. Together, these studies provide evidence that variations in CHRNA4 influence ND.
Box 1 | Definition of addiction and challenges in addiction genetics research
Diagnostic assessment of addiction: nicotine dependence as an example Drug addiction is characterized by a compulsion to take a substance, with goal-directed behaviour towards excessive substance intake and a loss of control in limiting intake. Clinical addictions generally are diagnosed using the Diagnostic and Statistical Manual IV (DSM-IV) 86 and the International Classification of Disease, Tenth Revision (ICD-10) from the World Health Organization (WHO) 87 . The most recent versions of DSM-IV and ICD-10 recognize two categorizes of addiction: abuse or harmful use, which is characterized by regular and increasing intake despite adverse consequences; and dependence, which in addition requires symptoms of withdrawal and/or tolerance.
Although there is significant co-morbidity among addiction to different drugs, the measurement of various addictions differs greatly. Here, we use nicotine dependence (ND) to illustrate the complexity of this behaviour. Historically, the assessment of ND has relied largely on the use of the Fagerström Tolerance Questionnaire 88 or a shorter version, the FTND
89
. Since these two scales were introduced, they have been used frequently in both clinical and research settings, partly because of their relationship to treatment outcome. However, the Fagerström scales were developed as unidimensional measures of physical tolerance 88 and thus do not assess some important aspects of ND, such as craving, subjective compulsion to smoke, nicotine withdrawal symptoms, behavioural saliency or behavioural automaticity, which often are regarded as core constructs of ND 90 . ND also can be assessed by diagnostic criteria based on the DSM-IV 86 . However, these symptoms are ultimately aggregated into a dichotomous classification as 'dependent' or 'not dependent', which limits its usefulness for research into the causes of addiction. Given that a diagnosis of dependence can be assigned by meeting various combinations of criteria, the diagnosis is conceptually heterogeneous. To expand the breadth of the diagnosis criteria and thereby improve the self-reported assessment of ND, new scales such as the Wisconsin Inventory of Smoking Dependence Motives 91 and the Nicotine Dependence Syndrome Scale 92 were developed. Whether these new scales can capture different aspects underlying ND and reduce the phenotypic heterogeneity among smokers remains to be investigated, especially in non-Caucasian smokers.
Genetic and phenotypic heterogeneity
One of the most significant challenges for genetic research into addiction concerns heterogeneity at both the phenotypic and genetic levels. Phenotypic heterogeneity is extensive in the manifestation of addiction, with users differing in the magnitude of numerous factors, such as age of onset of problems, drug symptoms, abusing history and co-morbid disorders. One means to reduce phenotypic heterogeneity is to classify more genetically or neurobiologically homogeneous phenotypes or to use endophenotypes as an intermediate phenotype between an addicted phenotype and the biological processes responsible for the manifestation of that disorder. Genetic heterogeneity is another important concern in genetic studies on addiction. Genetic differences exist between different ethnic groups or samples from different geographic locations. One way to minimize the effect on final genetics findings is to increase sample size and use more homogeneous samples. Nature Reviews | Genetics summary of chromosomal locations of nominated peaks or intervals for addictions to alcohol, cannabis, cocaine, heroin, nicotine and opoids. each linkage is shown with either a colour-filled circle or a rectangle, representing a reported linkage peak or region, respectively. 'significant' or 'suggestive' linkage was determined by independent studies on at least two substances of abuse. The determination of significant or suggestive linkage at each linkage peak or interval was based on the rigorous criteria proposed by Lander and Kruglyak 34 , which define a logarithm of odds (LoD) score greater than 3.6 or a p value less than 2.2 × 10 -5 as a significant linkage, and an LoD score greater than 2.2 but less than 3.6 or a p value less than 7.4 × 10 -4 as a suggestive linkage. each colour represents a type of abused substance. The unit for each chromosome is cM.
Association and interaction analysis of CHRNB2. By contrast, no significant association of CHRNB2, which encodes the β2 subunit, with ND was reported in four independent studies (for example, see Refs 35, 36) , except for a significant association of rs2072661, found in the 3′uTR of the gene, with ability to quit smoking 38 . However, epistatic analysis using a generalized multifactor dimensionality reduction method 39 revealed that CHRNB2 has a significant effect on ND when analysed together with CHRNA4 (Ref. 40) . The failure to detect significant association of CHRNB2 with ND by itself may thus be attributable to the small effect of CHRNB2 or the strong dependency of CHRNB2 effects on specific CHRNA4 variants. More importantly, detection of significant interaction of CHRNB2 with CHRNA4 in humans is consistent with the formation of functional nAChRs containing these two subunits (α4β2 nAChRs) 41, 42 . A moderate association of CHRNB2 with early response to alcoholism has also been reported 43 .
The recent development of selective partial agonists of α4β2 nAChRs as effective smoking cessation agents further supports the role of α4β2 nAChRs in ND. For example, the partial α4β2 nAChR agonist varenicline was approved by the us Food and Drug Administration as an aid to smoking cessation. It produces significantly higher quit rates (2-3 times) than other treatments 44 . varenicline can selectively decrease ethanol consumption and seeking in animals, implying it may be valuable also for treating alcoholism 45 .
Association of CHRNA5, A3 and B4 with ND and lung cancer. Three recent GWA studies suggested a strong association between lung cancer and variants of CHRNA5, CHRNA3 and CHRNB4 (encoding subunits α5, α3 and β4, respectively) on chromosome 15q24 (Refs 46-48) . However, although one study revealed a significant association of a CHRNA3 sNp with ND 48 , the other two studies suggested association of this and other variants with lung cancer independent of their association with smoking 46, 47 . several other studies provide independent verification of the association between this gene cluster and ND [49] [50] [51] , and suggest that power, precision of phenotyping or severity may explain the apparent association with lung cancer rather than a direct, smoking-independent association. We feel that a biological link between variants in the CHRNA5-A3-B4 cluster and ND is more plausible than a direct effect of these variants on lung cancer.
Association of CHRNA5, A3 and B4
with alcohol and cocaine dependence. Association of the CHRNA5-A3-B4 gene cluster with alcohol and cocaine addictions has been reported. Wang et al. 52 identified a group of sNps across the CHRNA5-A3 locus associated with AD. Because these variants are in low linkage disequilibrium (LD) with the sNps associated with ND and lung cancer, the authors concluded that CHRNA5-A3 variants are associated with AD, but through different sNps and mechanisms from those identified in ND and lung cancer. Moreover, Grucza et al. 53 found that a non-synonymous polymorphism in CHRNA5 has the opposite effect on cocaine dependence (CD) than the effect associated with ND. such contradictions in allelic associations are also found in other psychiatric disorders 54 . It remains to be seen whether there is true heterogeneity of association (in this case, between ND and CD), or whether some findings will turn out to be false positives.
Future research on the CHRNA5-A3-B4
cluster. Further steps are required to characterize the CHRNA5-A3-B4 cluster as a susceptibility locus for addictions and lung cancer. First, it is important to determine which variant (or variants) cause such significant associations. Resequencing might identify additional variants that explain the complex patterns, but functional Nature Reviews | Genetics analysis also will be necessary. The nonsynonymous variant rs16969968 causes the substitution of a negatively charged residue (Asp398) with a residue with no charge (Asn). This substitution is in the M3-M4 intracellular loop of CHRNA5
, a region that is thought to be involved with receptor trafficking. Indeed, the variant form of CHRNA5 alters receptor function without affecting expression 55 . second, it is important to determine whether the CHRNA5-A3-B4 cluster also has a significant role in non-European populations. Third, more research is needed to determine which smoking-related behaviour drives the association with this cluster. For example, ND was measured by smoking quantity in two studies 48, 50 , whereas another focused on searching for susceptibility genes underlying the transition from regular non-dependent to dependent smokers 49 . Weiss et al. 51 found a significant association of the cluster with ND only in early onset smokers. Fourth, other genes in the region, such as the hypothetical locus LOC123688, cannot be excluded because of the association with other sNps in this cluster 47 . However, this issue may be difficult to solve genetically because of the extensive LD structure.
Associations of other genes with addictions.
Although many candidate genes have been associated with addiction, few findings have been replicated (see TABLe 1 for verified and  supplementary information s1 (table) for  non-verified genes associated with multiple  substances, and supplementary information  s2 (table) for genes associated with only one substance). Given the controversial association reports for many genes, we focus on genes that have not only received strong statistical support for association with multiple substances of abuse but that also have greater biological support.
variants in GABRA2 are strongly associated with alcoholism [24] [25] [26] [27] , but an association has been reported between GABRA2 variants and addiction to nicotine and polysubstance abuse 56, 57 . Furthermore, a linkage study has implicated the region near GABRA2 in the aetiology of cannabis use 58 . variants in ANKK1, encoding a protein kinase involved in signal transduction 59 , have also been associated with susceptibility to ND 60, 61 , AD 62, 63 , and co-morbid alcohol and drug dependence 64 . Finally, several GWA studies provide evidence for the involvement of cell adhesion-related genes in vulnerability to addiction and other psychiatric disorders 65 . Representative members of this category include neurexin 1 for ND 66, 67 and neurexin 3 for polysubstance 65 , alcohol 68 and opioid abuse 69 . Rare mutations in several members of this gene family, including neurexin 1, also have been associated with autism 54, 70 and schizophrenia 71 , implying that the members of this family are important in many psychiatric disorders.
Murine behavioural studies Knockout (KO) models of nAChR subunit genes. Genes encoding nAChR subunits mediate variability in many of the behavioural effects of nicotine. KO mice for nAChR subunits α3-α9 and β2-β4 have shown that the deletion of these genes alters many effects of nicotine. unlike wild-type animals, mice lacking the α4 and β2 subunits do not self-administer nicotine and do not show nicotine-induced increases of dopamine levels in the ventral stratum 72, 73 . In addition, β2 KO mice self-administer cocaine but fail to maintain self-administration when cocaine is switched to nicotine 72 , and α4 KO mice exhibit a prolonged motor response to cocaine 73 . Together, the findings from α4 and β2 KO mice provide evidence that α4β2* (* indicates another undetermined subunit) nAChRs are required for proper regulation of dopamine release and for maintenance of self-administration and reinforcement.
KO mice of α5 (Ref. 74) and β4 (Ref. 75 ) subunits, as well as α3 KO heterozygous
Box 2 | Composition and function of nAChRs in the brain
Neuronal nicotinic acetylcholine receptors (nAChRs) belong to a superfamily of ligand-gated ion channels that also includes receptors for gamma-aminobutyric acid (GABA), glutamate, glycine and serotonin. nAChRs are pentameric complexes assembled from an extensive family of subunits. In vertebrates, 12 nAChR subunit genes with a common ancestor have been cloned and classified into two subfamilies of nine alpha (α2-α10) and three beta (β2-β4) subunits. There is considerable subunit diversity among nAChR subtypes and, consequently, receptor subtypes are commonly referred to by their subunit composition.
nAChRs are widely distributed in the brain, and their subunit composition is cell and region specific. Most nAChRs in the nervous system contain one type of α and one type of β subunit, with α4β2 receptors accounting for 90% of the high-affinity nAChRs in the brain; α3β4 receptors are the main subtype in the autonomic ganglia and adrenal medulla and in subsets of central nervous system neurons. The α4β2 and α3β4 subtypes also can contain the α5 subunit, which is believed to increase the rate of channel desensitization and calcium permeability.
Because nAChRs are the primary site of action for nicotine in the brain, they are important targets for the development of therapeutic agents that facilitate smoking cessation efforts. nAChRs are composed of five subunits that combine to form a functional receptor (see the figure, part a) . Each subunit comprises four membrane-spanning domains, which are arranged in concentric layers around a central aqueous pore with the M2 domains lining the pore. Following nAChR activation by an endogenous agonist (acetylcholine, for example) or exogenous agonist (such as nicotine), the domains of each of the five nAChR subunits rearrange such that the central pore opens and permits cationic trafficking (see the figure, part b). Nicotine binds at the interface between the α and β subunits in heteromeric nAChRs to activate the receptor (see the figure, part c) . Activation of nAChRs can potentiate neurotransmitter release (when expressed at presynaptic terminals) and neuronal excitability (when expressed at postsynaptic terminals) throughout the brain. As a result, nAChRs contribute to a wide range of brain activities, including cognitive functions, and neuronal development and degeneration. Nicotine dependence is initiated through the activation of nAChRs. Chronic nicotine exposure produces the long-lasting physiological and behavioural changes associated with addiction, including nAChR upregulation and gene expression alteration, and long-term potentiation and depression induction at glutamatergic synapses.
Glossary

Behavioural automaticity
Control of behaviour by external stimuli and events in the immediate environment, often without knowledge or awareness of such control.
Behavioural saliency
In the context of this article, the likelihood and the degree to which a stimulus elicits a reaction or response.
Depression induction
A procedure that induces a state of depression.
Endophenotype
In psychiatry, a biomarker for a behavioural symptom that has a clear genetic connection.
Genetic heterogeneity
Causation of a disorder or trait by different genetic variants in different samples. This can arise when participants of different ethnic origins are included, genetic effects or samples are small, and marker density is low.
Haplotype
A combination of the alleles at different loci on the same chromosome.
Heritability
The proportion of phenotypic variance that can be attributed to variance of the genotype.
Linkage mapping
Linkage refers to the tendency of two close loci on the same chromosome to co-segregate within a pedigree. Genome-wide linkage scanning can identify loci that are involved in conditions for which there is no a priori reason to suspect any contribution.
Long-term potentiation
The long-lasting improvement in communication between two neurons that results from stimulating them simultaneously.
Multifactor dimensionality reduction method
A data reduction approach for detecting combinations of attributes or independent variables that interact to influence a binary outcome.
Positional candidate gene approach
A candidate gene-based association study that focuses on a genome region identified from linkage analysis.
QTL mapping
The statistical study of the genetic loci that contribute to variations in a quantitative trait or phenotype. mice 76 , show that each of the three genes in a cluster on chromosome 15 mediates similar effects of nicotine; that is, the animals show resistance to nicotine-induced seizures, and the α5 and α3 subunits mediate both the locomotion-suppressant effects of nicotine and the somatic signs of nicotine withdrawal.
Knockin (KI) model of nAChR subunit α4 in nicotine addiction. To better understand the roles of α4-containing nAChRs, a KI approach was adopted with the goal of making a hypersensitive nAChR that might generate more noticeable phenotypes. One of the most successful examples of this approach was the generation of two lines of α4 KI mice by introducing a point mutation into the M2 transmembrane region of the α4 subunit 77, 78 . In Leu9′ser KI mice, this mutation produces α4-containing nAChRs with an approximately 30-fold increase in sensitivity to acetylcholine and nicotine. Heterozygous KI mice exhibit greater anxiety, impaired motor learning, excessive ambulation that is eliminated by small amounts of nicotine, and reduction of dopaminergic function on ageing 78 . By contrast, both homozygous and heterozygous Leu9′Ala KI mice are exceptionally sensitive to nicotine and ND-related behaviours, including reward, tolerance and sensitization 77 . These findings suggest that genetic variability in the α4 subunit can produce dramatic changes in nicotine sensitivity, implying that a variant (or variants) in the human CHRNA4 gene alters sensitivity to nicotine and vulnerability to ND. Mouse models of GABA genes in alcohol and other addictions. Rodent models of addiction have been studied for decades 79 . QTL mapping of alcohol withdrawal identified several loci reproducibly: for example, one replicated locus involves nonsynonymous variants in GABRA2 (Ref. 80) . Deletion of GABA A receptor α1 or β2 subunits leads to reduced loss of the righting reflex (which tends to bring the body into a normal position) in response to alcohol, as well as reduced consequences in response to other drugs 81 . Conversely, sensitivity to alcohol can be manipulated by overexpression or reduction of the activity of the GABA transporter 82 . Overall, many other mutants, including KI, KO and transgenic mice of various GABA subunit genes, ABA in mediating the behavioural consequences of alcohol 79 and other drugs 83 . The specific genes and alleles may differ from those associated in humans but, overall, animal models have confirmed and extended findings of the involvement of GABA in AD and other addictions 79, 83 . The molecular mechanisms of the effects of GABA are being established by microarray analysis 79, 84 . Conclusions significant progress has been made in identifying susceptibility loci and genes for addictions. Comparison of linkage peaks for addictions to various substances confirms what we have learned from genetic epidemiological studies, namely that genetic vulnerability to different substances in part overlaps. variants in several genes, including aldehyde dehydrogenases, GABRA2, ANKK1, and neurexins 1 and 3, have been associated with addictions to multiple drugs. Most recently, variants of the CHRNA5-A3-B4 cluster on chromosome 15 were found by GWA and targeted studies to be associated not only with addictions to tobacco, alcohol and cocaine, but also with lung cancer. These genes have effects on nicotine responses in animal models and can thus be considered established targets for these studies. Nevertheless, the exact nature of the variants and their functions are still unknown. Functional studies as well as studies in other ethnic populations with different LD structures may be revealing. Confirmation of candidate gene findings by GWA studies is reassuring; this is similar to the robust findings in type II diabetes 85 but lies in sharp contrast to GWA results in other psychiatric disorders, which so far have failed to replicate any candidate findings 54 . such candidate genes with prior biochemical evidence and animal models allow a quicker move to functional studies. Well-designed GWA studies with large samples should help to identify additional genes, including genes that implicate novel biological pathways involved in addiction.
